All European Society of Cardiology Congress articles
-
NewsScientists report the first use of CRISPR activation to treat a cardiac disease in mice
Researchers have demonstrated for the first time that CRISPR-based gene activation (CRISPRa) can be used to treat genetic heart disease in vivo. The study paves the way for novel targeted therapies for patients with genetic cardiac disorders.